Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Interactions of Piperaquine, Pyronaridine and Artesunate in Healthy Adults
NCT07470424Phase 1Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Nov 2026
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of piperaquine and artesunate + pyronaridine in malaria (6 arms), sponsored by University of Oxford. Primary endpoints: Number of adverse events at 6 months, Number of events concerning of abnormal electrocardiographic at 6 months and 2 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
piperaquineartesunate + pyronaridine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07470424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07470424.